Park Square has placed Eric Hyllengren as Chief Financial Officer at Tenaya Therapeutics.
| less than a minute read
Tenaya Therapeutics Appoints Eric Hyllengren as Chief Financial Officer
Get in touch
Get in touch
Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced the appointment of Eric Hyllengren as Chief Financial Officer, effective July 13, 2026.
Get in touch
Get in touch
Latest Insights
